VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BWXT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BWXTBWX Technologies, Inc.
$118.82$10.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBWXTFinancials

BWX Technologies, Inc. (BWXT) Income Statement

18Y historyFree accessUpdated daily

Revenue expanded from $682.3M in 2025Q1 to $953.0M in 2026Q3 with gross margin recovering to 23.8%, but operating margin of 13.9% and net margin of 10.7% have not yet shown consistent operating leverage over the period.

Income StatementBalance SheetCash FlowRatios

BWXT Income Statement

Annual statement

BWXT Income Statement

BWX Technologies, Inc. (BWXT) annual income statement — 18-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
Sales/Revenue3.6B3.2B2.7B2.5B2.23B2.12B2.12B1.89B1.8B1.69B1.55B1.42B1.45B1.55B3.29B2.95B2.69B2.85B3.4B
Revenue Growth %17.74%18.3%8.31%11.8%5.12%0.03%12.06%5.28%6.64%8.85%9.54%-2.42%-6.21%-53.01%11.49%9.79%-5.81%-16%-
Cost of Goods Sold2.79B2.47B2.05B1.88B1.68B1.57B1.55B1.36B1.3B1.17B1.07B1.03B2.41B2.3B2.46B2.28B2.02B2.24B2.68B
COGS % of Revenue-77.13%75.77%75.14%75.28%74.09%72.9%71.83%72%69.37%69.3%72.58%166.09%148.81%74.78%77.17%75.28%78.31%78.8%
Gross Profit813.32M731.52M655.21M620.59M551.93M550.28M575.4M533.86M504.01M516.88M476.04M388.09M513.64M967.56M830.15M673.83M664.78M619.25M720.64M
Gross Margin %22.58%22.87%24.23%24.86%24.72%25.91%27.1%28.17%28%30.63%30.7%27.42%35.41%62.56%25.22%22.83%24.72%21.69%21.2%
Gross Profit Growth %-11.65%5.58%12.44%0.3%-4.37%7.78%5.92%-2.49%8.58%22.66%-24.44%-46.91%16.55%23.2%1.36%7.35%-14.07%-
Operating Expenses434.12M408.28M274.6M237.53M203.36M204.43M216.84M208.34M199.04M203.53M229.81M182.15M272.45M227.36M483.56M472.21M407.61M402.94M276.16M
OpEx % of Revenue-12.77%10.16%9.52%9.11%9.62%10.21%10.99%11.06%12.06%14.82%12.87%18.78%14.7%14.69%16%15.16%14.12%8.13%
Selling, General & Admin444.2M394.42M318.66M279.69M234.28M230.4M231.17M216.77M214.09M214.61M216.49M207.76M442.62M379.38M428.29M413.21M405.68M403.56M337.55M
SG&A % of Revenue-12.33%11.79%11.2%10.49%10.85%10.89%11.44%11.89%12.72%13.96%14.68%30.51%24.53%13.01%14%15.09%14.14%9.93%
Research & Development15.9M13.87M7.48M7.61M9.54M11.06M14.19M17.67M15.22M7.19M6.41M10.54M73.23M79.23M120.56M106.4M69.17M00
R&D % of Revenue-0.43%0.28%0.3%0.43%0.52%0.67%0.93%0.85%0.43%0.41%0.74%5.05%5.12%3.66%3.6%2.57%--
Other Operating Expenses-1000K0-51.54M-49.77M-40.45M-37.03M-28.51M-26.1M-30.28M-13.81M13.89M-36.15M-12.68M-28.55M-65.29M-81.74M-74.04M-53.87M-61.4M
Operating Income379.37M323.24M380.61M383.06M348.57M345.85M358.55M325.52M304.98M292.22M234.43M205.94M25.13M306.91M346.59M95.67M248.85M269.56M444.48M
Operating Margin %10.53%10.11%14.08%15.35%15.61%16.28%16.88%17.18%16.94%17.31%15.12%14.55%1.73%19.84%10.53%3.24%9.26%9.44%13.08%
Operating Income Growth %--15.07%-0.64%9.89%0.79%-3.54%10.15%6.74%4.36%24.65%13.83%719.67%-91.81%-11.45%262.27%-61.56%-7.68%-39.35%-
EBITDA502.81M432.43M466.47M461.63M422.41M414.93M419.23M387.24M365.07M348.78M284.98M284.56M130.92M377.44M416.29M168.67M320.49M342.28M524.2M
EBITDA Margin %13.96%13.52%17.25%18.49%18.92%19.53%19.74%20.44%20.28%20.67%18.38%20.1%9.03%24.4%12.65%5.71%11.92%11.99%15.42%
EBITDA Growth %3.56%-7.3%1.05%9.28%1.8%-1.03%8.26%6.07%4.67%22.39%0.15%117.35%-65.31%-9.33%146.8%-47.37%-6.37%-34.71%-
D&A (Non-Cash Add-back)123.44M109.19M85.86M78.57M73.84M69.08M60.67M61.72M60.1M56.56M50.55M78.62M105.8M70.53M69.7M73M71.63M72.71M79.72M
EBIT450.36M442.33M388.19M368.44M350.79M431.47M393.19M349.06M307.97M310.66M265.66M231.25M39.22M288.17M323.15M99.04M233.15M256.89M455.48M
Net Interest Income-10.46M-40.31M-36.92M-44.68M-35.65M-35.34M-30.5M-34.38M-25.34M-13.47M-7.74M20.15M-6.85M-2.44M-2.24M-3.2M-11.75M-21.15M-7.45M
Interest Income15.12M3.89M2.55M2.36M758K416K518K942K2.48M1.41M651K30.33M233K215K1.49M1.34M1.19M3.44M15.29M
Interest Expense25.58M44.21M39.48M47.04M36.41M35.76M31.01M35.32M27.82M14.88M8.39M10.18M7.09M2.65M3.73M4.54M12.94M24.59M22.74M
Other Income/Expense74.42M74.88M-31.89M-61.66M-34.19M49.87M3.62M-11.78M-24.83M-13.11M22.84M15.12M-19.66M210.26M-27.17M139.26M-28.15M15.18M-11.74M
Pretax Income453.79M398.12M348.72M321.4M314.38M395.71M362.17M313.74M280.14M295.78M257.27M221.06M5.47M517.17M319.42M234.94M235.82M232.3M432.74M
Pretax Margin %12.6%12.45%12.9%12.88%14.08%18.63%17.06%16.56%15.56%17.53%16.59%15.62%0.38%33.44%9.7%7.96%8.77%8.14%12.73%
Income Tax77.84M68.26M66.42M75.08M75.76M89.42M82.98M69.06M52.84M147.41M73.66M80.42M-15.99M184.58M101.86M72.98M82.29M84.38M108.89M
Effective Tax Rate %17.15%17.15%19.05%23.36%24.1%22.6%22.91%22.01%18.86%49.84%28.63%36.38%-292.55%35.69%31.89%31.06%34.9%36.32%25.16%
Net Income374.9M329.86M281.94M245.85M238.19M305.87M278.67M244.12M226.96M147.84M183.06M131.47M29.39M346.08M227.69M169.65M153.26M147.76M323.77M
Net Margin %10.41%10.31%10.43%9.85%10.67%14.4%13.12%12.88%12.61%8.76%11.81%9.29%2.03%22.38%6.92%5.75%5.7%5.18%9.53%
Net Income Growth %22.1%17%14.68%3.22%-22.13%9.76%14.16%7.56%53.51%-19.24%39.24%347.34%-91.51%51.99%34.21%10.7%3.72%-54.36%-
Net Income (Continuing)375.95M329.86M282.3M246.32M238.62M306.29M279.2M244.68M227.31M148.37M183.61M140.65M30.44M184.71M217.56M161.95M153.53M147.92M323.85M
Discontinued Operations0000000000000147.88M00000
Minority Interest-60K525K-276K-50K45K60K2K6K39K363K392K13.92M15.5M18.25M16.48M9.18M666K00
EPS (Diluted)4.083.593.072.682.603.242.912.552.271.471.761.220.273.071.910.661.191.262.76
EPS Growth %22.46%16.94%14.55%3.08%-19.75%11.34%14.12%12.33%54.42%-16.48%44.26%351.85%-91.21%60.73%189.39%-44.54%-5.56%-54.35%-
EPS (Basic)-3.603.082.682.603.242.922.562.291.491.791.230.273.091.920.671.201.272.79
Diluted Shares Outstanding91.99M91.86M91.86M91.87M91.7M94.52M95.73M95.81M100.02M100.37M103.84M107.58M108.76M112.69M119.02M118.4M117.63M117.42M117.42M
Basic Shares Outstanding91.73M91.57M91.57M91.62M91.45M94.28M95.46M95.38M99.06M99.33M102.47M106.7M108.48M111.9M118.42M117.56M116.26M116.07M116.07M
Dividend Payout Ratio-28.03%31.34%34.56%34.04%26.05%26.17%26.78%28.12%28.44%20.41%26.23%147.91%10.98%4.17%12.29%13.34%--

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Government program timing concentration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Reaccelerating Into 2026

Based on reported figures, BWXT's quarterly revenue rose from $682.3M in 2025Q1 to $953.0M in 2026Q3, with year-over-year growth reaccelerating to 10.0% in the latest quarter after a trough near 2.9% in 2024Q4 driven by government program timing.

The sequence of year-over-year growth rates, moving from low single digits in late 2024 to 18.0% and 26.2% in early 2026, suggests the revenue base is inflecting rather than simply recovering from a soft comparison. The latest quarter's deceleration to 10.0% from the prior 18.0% indicates the growth rate may be normalizing, which warrants monitoring to determine whether the naval program throughput is sustainable. Investors should monitor whether volume gains from the Navy reactor cadence, rather than pricing, are driving the trend.

Gross Margin Recovering Toward Prior Peak

According to reported financial statements, BWXT's gross margin expanded from a 21.0% trough in 2025Q4 to 23.8% in 2026Q3, approaching the 24.4% to 25.1% range seen across 2024 and mid-2025 quarters.

The margin recovery suggests improved execution or favorable contract mix on the cost-plus government work, though the cyclical trough in late 2025 indicates meaningful quarterly volatility tied to percentage-of-completion adjustments. The current level remains below the mid-2025 peak, which may indicate that the recent expansion is partly a rebound rather than a structural step-up. Investors should monitor whether the commercial isotope mix can lift margins durably above the mid-20s range.

Operating Leverage Remains Modest

As reported in financial statements, BWXT's operating margin reached 13.9% in 2026Q3 versus 14.2% in 2025Q1, indicating that operating income has not yet consistently outpaced gross profit growth despite the revenue expansion.

Because SG&A has grown in step with revenue, operating income has tracked gross profit rather than compounding faster, which suggests limited incremental overhead leverage at current scale. The operating margin's inconsistency across recent quarters, ranging from 8.1% to 14.4%, implies that the cost base carries meaningful variability. This pattern may indicate that operating leverage will depend on sustained program volume rather than structural efficiency gains.

Net Income Diverges From Operating Trend

Based on EPS-reported figures, BWXT's diluted EPS of $1.11 in 2026Q3 reflects a net margin of 10.7%, while net income fell to $71.5M in 2025Q4 despite revenue of $885.8M, indicating that below-the-line items may be contributing meaningful volatility.

The gap between operating income and net income in several quarters, such as 2025Q1 where net income exceeded operating income, suggests non-operating items or tax effects are influencing reported earnings. Stock-based compensation of $5.0M to $10.2M per quarter is modest relative to net income, so it does not appear to be the primary distortion. Investors should monitor the tax rate and non-operating line items to assess how much of the EPS trajectory reflects underlying operations.

Fixed Cost Base Dominates Structure

Based on reported figures, COGS consumed roughly 76% of revenue in 2026Q3 at $725.8M, while R&D remained negligible at $3.8M and SG&A totaled $117.2M, indicating that production cost control drives the margin profile.

The cost structure is dominated by cost of sales, which is consistent with a high-fixed-cost manufacturing base carrying specialized labor and facilities. The R&D line is very small relative to revenue, which suggests the medical isotope and SMR development spending may be partly capitalized or embedded elsewhere, warranting further investigation. Investors should monitor whether SG&A growth remains proportional to revenue as the company scales commercial initiatives.

Program Timing Could Reverse Growth

Based on reported figures, the sharp swing in quarterly revenue growth from 2.9% to 26.2% within two years suggests the top line is highly sensitive to government program timing, which may not persist if procurement schedules slip.

A bear case would focus on whether the 18.0% and 26.2% growth prints reflect one-time catch-up on percentage-of-completion milestones rather than durable volume expansion. The latest deceleration to 10.0% and the already-declining net income trend in late 2025 could be early signals that the cycle is peaking. Investors should monitor reported backlog conversion and any changes in Columbia-class production cadence before extrapolating current growth rates.

BWXT — Frequently Asked Questions

Quick answers to the most common questions about buying BWXT stock.

What was BWX Technologies, Inc.'s (BWXT) revenue in 2025?

For fiscal year 2025, BWX Technologies, Inc. (BWXT) reported total revenue of $3.20B. This represents a 5.9% decline compared to $3.40B in 2008.

Is BWX Technologies, Inc. (BWXT) profitable?

BWX Technologies, Inc. (BWXT) is profitable, generating $329.9M in net income for the fiscal year ending 2025 with a net profit margin of 10.3%.

What is BWX Technologies, Inc.'s operating profit margin?

BWX Technologies, Inc. (BWXT) reported an operating income of $323.2M, resulting in an operating profit margin of 10.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is BWX Technologies, Inc.'s gross profit and gross margin?

BWX Technologies, Inc. (BWXT) generated $731.5M in gross profit for the year, representing a gross profit margin of 22.9%. This demonstrates the company's core pricing power and production efficiency.